With the beginning of June, Motilal Oswal brokerage firm has given relief to investors who are looking for the right stocks. The company has released a list of 8 selected shares, in which it has been estimated from 14 percent to 32 percent in the coming time. Let us understand what the story behind these shares gave him a by rating.

SBI (State Bank of India)

Target Price: 925 rupees, UPSIDE POTENIAL: 14 %

The country’s largest public sector bank SBI is the first in this list. The bank’s performance in FY25 has been strong, control over non -performing assets, stable balance sheet and good growth. The company estimates that SBI’s earnings between FY25 and FY27 will have a 6 % CAGR growth.

Adani Ports & Sez (Apsez)

Target Price: Rs 1,700, UPSIDE POTYANAL: 19 %

Adani Ports is preparing to increase its logistics business by 5 times. By FY29, earnings up to Rs 140 billion are estimated. Motilal Oswal, the dream of converting the company into a multi-utility transport hub, feels very reliable.

Apollo Hospitals

Target Price: Rs 8,050, UPSIDE POTENAL: 17 percent

There is a improvement in digital health and diagnostics segment in Apollo Hospitals. Between FY25–27, 15 percent revenue and 23 percent PAT CAGR are expected.

Present Estates Projects

Target Price: Rs 1,938, UPSIDE POTENAL: 32 percent

This stock is one of the highest returns shares due to the strong pipeline of residential and commercial projects and value unlocking from the hospitality sector.

IPCA Laboratories

Target Price: Rs 1,750, UPSIDE POTENAL: 17 percent

The benefits of the purchase of domestic formulation segment and Unichem are supporting the growth of the company. 18 % Ebitda Cagr expected during FY25–27.

Sobha ltd.

Target Price: Rs 1,778, UPSIDE POTENIAL: 24 %

This real estate company from Bengaluru is attracting investors due to its strong land and cashflow. Monetage of new projects and 154 million square feet of land is giving a strong base to its growth.

Lemon Tree Hotels

Target Price: Rs 200, UPSIDE POTENALIAL: 16 percent

The opening and rising room rates of hotels like Aurika Mumbai has re -speeded the company. This growth is likely to grow further in FY26.

Spandana sphoorty

Target Price: Rs 340, UPSIDE POTENAL: 17 percent

Although FY25 was a bit weak, the company’s loan collection is getting better. Brokers are showing confidence again in the company with 18 % CAGR and better Roe/ROA in AUM by FY27.

Disclaimer: (Information provided here is being given only for information. It is necessary to tell here that the investment market is subject to risks. Always consult expert before investing as an investor. Never is advised to invest money from Abplive.com.

Also read: PM Modi gets less salary than fresher working in Microsoft, read the full report here